Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record’s update history now reflects a submission on November 11, 2026, and a posting on November 13, 2026, replacing the earlier dates.
    Difference
    0.1%
    Check dated 2026-11-17T14:55:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the cabozantinib and nivolumab endometrial cancer study is displayed, with study details, results information, and supporting documents.
    Difference
    100%
    Check dated 2026-11-10T14:38:24.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:47:06.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:30:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-13T14:40:31.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the preceding study details and document links with an access-denied message.
    Difference
    23%
    Check dated 2026-09-22T21:00:41.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.